We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · August 12, 2021

Risk of Pneumonitis in Cancer Patients Treated With PARP Inhibitors

Gynecologic Oncology


Additional Info

Gynecologic Oncology
Risk of Pneumonitis in Cancer Patients Treated With PARP Inhibitors: A Meta-Analysis of Randomized Controlled Trials and a Pharmacovigilance Study of the FAERS Database
Gynecol. Oncol 2021 Aug 01;162(2)496-505, Z Ma, X Sun, Z Zhao, W Lu, Q Guo, S Wang, J You, Y Zhang, L Liu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading